PRECISION BIOSCIENCES INC
PRECISION BIOSCIENCES INC (DTIL): 16 pipeline candidates · ~32 mo cash runway · 7 clinical trials. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
32.1 months
D/E 0.89 · 0% dilution
Lead: Approved
16 candidates
N/A
0 buys · 8 sells (180d)
A transparent, data-derived signal for PRECISION BIOSCIENCES INCacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$167.7M
Cash
$125.8M
Quarterly Burn
$11.9M
Runway
32.1 mo
Revenue
$10.8M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (16 candidates)
| Drug | Phase |
|---|---|
| ammonia n 13 | Approved |
| bgm-2121 | Phase 1 |
| ecur-506 | Phase 1/Phase 2 |
| fludeoxyglucose f18 | Approved |
| fosfomycin | Approved |
| pbgene-3243 | Preclinical |
| pbgene-cns | Phase 1/Phase 2 |
| pbgene-dmd | Phase 1/Phase 2 |
| pbgene-hbv | Phase 1 |
| pbgene-liver | Phase 1 |
Showing 10 of 16 candidates. Sign up for full pipeline.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
74
Total value held
$48.5M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 1,821,480 | $10.0M |
| boothbay fund management, llc | 1,066,050 | $5.9M |
| driehaus capital management llc | 995,371 | $5.5M |
| lynx1 capital management lp | 985,113 | $5.4M |
| affinity asset advisors, llc | 597,946 | $3.3M |
| marshall wace, llp | 415,671 | $2.3M |
| two sigma investments, lp | 307,790 | $1.7M |
| geode capital management, llc | 287,090 | $1.6M |
| renaissance technologies llc | 223,177 | $1.2M |
| blackrock, inc. | 199,761 | $1.1M |
Showing top 10 of 74 institutional holders of PRECISION BIOSCIENCES INC. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in PRECISION BIOSCIENCES INC's pipeline?
PRECISION BIOSCIENCES INC (DTIL) has 16 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is PRECISION BIOSCIENCES INC's lead drug candidate?
PRECISION BIOSCIENCES INC's most advanced tracked candidate is ammonia n 13 (Approved).
What is PRECISION BIOSCIENCES INC's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, PRECISION BIOSCIENCES INC has approximately 32.1 months of cash runway.
What is PRECISION BIOSCIENCES INC's market capitalization?
PRECISION BIOSCIENCES INC's market capitalization is approximately $167.7M.
Who is the CEO of PRECISION BIOSCIENCES INC?
Mr. Michael Amoroso is the chief executive officer of PRECISION BIOSCIENCES INC (DTIL).
Get the full picture on PRECISION BIOSCIENCES INC
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.